Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Commissioner McClellan

This article was originally published in The Tan Sheet

Executive Summary

White House health and economic advisor Mark McClellan, MD/PhD, unanimously confirmed by Senate Oct. 17 after Health Committee member Jeff Bingaman (D-N.M.) lifted hold on nomination (1"The Tan Sheet" Oct. 14, 2002, p. 7). Confirmation comes 21 months after former Commissioner Jane Henney, MD, left office. Although no swearing-in date had been set as of Oct. 18, FDA's Science Board meeting in Rockville, Md. Oct. 25 could mark his first public appearance as commissioner. Meeting agenda lists introductory remarks to be given by McClellan "pending confirmation." Meeting will include discussion of CFSAN counterterrorism efforts, CDER's drug GMP initiative...

You may also be interested in...

FDA's Next Commissioner: Will Trump Follow Hamburg Or McClellan 'Schedule'?

Nothing seems conventional about this presidency, but history suggests a nomination may not arrive for another month or longer, and thereafter confirmation could be swift.

FDA commissioner

White House health and economic advisor Mark McClellan, PhD/MD, sworn in as FDA commissioner Nov. 14. McClellan was unanimously confirmed by the Senate Oct. 17 (1"The Tan Sheet" Oct. 21, 2002, In Brief). During groundbreaking ceremony for new FDA facilities in White Oak, Md., McClellan delivered his first official speech as commissioner, stressing the importance of employee morale, recruitment and retention...

McClellan to start after elections

Incoming FDA Commissioner Mark McClellan, MD/PhD, will be sworn in and start at FDA Nov. 8. Currently a White House health policy advisor, McClellan was cleared by the Senate Oct. 17 (1"The Tan Sheet" Oct. 21, 2002, In Brief)...

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts